Literature DB >> 11748579

Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies.

J Liu1, C V Fanning.   

Abstract

BACKGROUND: The reliability of using fine-needle aspiration (FNA) to distinguish renal oncocytoma (RO), a benign tumor, from renal cell carcinoma (RCC), which has eosinophilic granular cytoplasm, has been questionable. However, it is clinically significant, because radical nephrectomy may be avoided in patients with RO. The authors retrospectively studied the cytologic features and ancillary study findings of RO compared with findings in RCCs with eosinophilic granular cytoplasm to evaluate the reliability of FNA-based diagnosis of RO.
METHODS: The authors reviewed 19 tumors, including 11 ROs, three chromophobe RCCs (CRCCs), three granular variant RCCs (GRCCs), and two eosinophilic variant papillary RCCs (EPRCCs). Smears and cell blocks were prepared using either computed tomography-guided or ultrasound-guided FNA material. Surgical specimens were available for all tumors. Cytokeratin, vimentin, and Hale colloidal iron (HCI) stains were performed on all 19 tumors. Electron microscopy (EM) was available for six tumors.
RESULTS: Although most tumors demonstrated their classic cytologic features, the specific diagnosis using conventional smears or even core biopsies was difficult in some tumors, especially ROs, due to the overlapping cytomorphology among these tumors. Cytologic material was obtained from 10 of 11 RO specimens. Of 10 ROs, 8 original FNA-based diagnoses were oncocytic neoplasm. Immunoperoxidase studies revealed that all tumors of each type were positive for cytokeratin, whereas only GRCCs and EPRCCs were positive for vimentin. The two vimentin negative neoplasms, RO and CRCC, could be distinguished by HCI stain, which showed diffuse or focal cytoplasmic positivity in CRCCs and apical/perinuclear staining (73%) or negative staining (27%) in ROs. Ultrastructurally, cytoplasm densely packed with mitochondria was characteristic for oncocytoma.
CONCLUSIONS: This study demonstrated that ROs can be distinguished reliably from RCCs on the basis of cytologic morphology combined with ancillary studies, including immunostaining with cytokeratin and vimentin antibodies and HCI stain. EM provides additional information to confirm the diagnoses. Cancer (Cancer Cytopathol) Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748579     DOI: 10.1002/cncr.10141

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.

Authors:  Margareta Strojan Fležar; Helena Gutnik; Jera Jeruc; Irena Srebotnik Kirbiš
Journal:  Virchows Arch       Date:  2011-11-04       Impact factor: 4.064

2.  Role of MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making.

Authors:  Taekmin Kwon; In Gab Jeong; Sangjun Yoo; JungBok Lee; Sungwoo Hong; Dalsan You; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Int Urol Nephrol       Date:  2015-02-14       Impact factor: 2.370

3.  Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.

Authors:  Ozgur Mete; Isin Kilicaslan; Mine G Gulluoglu; Veli Uysal
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

4.  Can renal oncocytoma be distinguished from chromophobe renal cell carcinoma by the presence of fibrous capsule?

Authors:  Alma Demirović; Sanja Cesarec; Borislav Spajić; Davor Tomas; Stela Bulimbasić; Milan Milosević; Zlatko Marusić; Bozo Kruslin
Journal:  Virchows Arch       Date:  2009-12-19       Impact factor: 4.064

Review 5.  Update on oncocytoma.

Authors:  Stephen M Schatz; Michael M Lieber
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

Review 6.  Imaging management of incidentally detected small renal masses.

Authors:  V Anik Sahni; Stuart G Silverman
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

7.  [Small incidental renal tumors. Evaluation and biological parameters].

Authors:  M Remzi; M Memarsadeghi
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

8.  Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells.

Authors:  G Yang; D G Rosen; J A Colacino; I Mercado-Uribe; J Liu
Journal:  Oncogene       Date:  2006-09-04       Impact factor: 9.867

Review 9.  Biopsy of renal masses: when and why.

Authors:  V Anik Sahni; Stuart G Silverman
Journal:  Cancer Imaging       Date:  2009-07-06       Impact factor: 3.909

Review 10.  Imaging and management of the incidentally discovered renal mass.

Authors:  Jonathon Willatt; Isaac R Francis
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.